CIK 0001855485 · <br>Emerging growth company
Calidi Biotherapeutics, Inc.
Sign in to watch- Tickers
- CLDI CLDWW
- Exchange
- NYSE, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 862967193
- Phone
- 858-794-9600
- Business address
- 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Calidi Biotherapeutics, Inc., First Light Acquisition Group, Inc.
Securities
- CLDI Calidi Biotherapeutics, Inc. Common Stock NYSE
- CLDWW Common stock OTC
- 8-K Event Bylaws or fiscal year change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Regulation FD disclosure
- 4 Grant or award Director acquired 67,187 shares (grant or award)
- 4 Grant or award Director acquired 79,687 shares (grant or award)
- 4 Grant or award Director acquired 73,437 shares (grant or award)
- 4 Grant or award Director acquired 23,783 shares (grant or award)
- 4 Grant or award Director acquired 28,207 shares (grant or award)
- 4 Grant or award Director acquired 25,995 shares (grant or award)
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- D Other Notice of Sales of Unregistered Securities
- 4 Option exercise Director acquired 548,000 shares (option exercise)
- 424B3 Offering Prospectus
Page 9 of 21 · 406 filings